Electrical fields designed to help the brain regain control of immune function by targeting the cholinergic
Electrical fields designed to help the brain regain control of immune function by targeting neurological pathways.
Nēsos was co founded by Konstantinos Alataris, Ph.D. and other neuroscientists that have successfully developed and commercialized electrical field treatments for neurological disorders. As the founder and former CEO of Nevro (NYSE: NVRO), Konstantinos led product development and the initial commercialization of Senza, Nevro's market-leading, implantable neuromodulator for the treatment of chronic pain. Nēsos is critically supported by expert clinical and scientific collaborators from leading academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University Of California, San Diego (UCSD), and the University Of California, San Francisco (UCSF).
EULAR 2020 Poster
ACR 2020 Oral presentation by Matt Baker MD (Stanford)
What If You Could Change Your Immune System By Wearing Earbuds? Meet The Startup That Could Make It Possible
Nēsos aims to treat diseases, by restoring neurological pathways that control immune function. Using engineered electrical signals delivered by a noninvasive brain interface. Nēsos is guided and supported by clinical and scientific collaborators from top academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University of California, San Diego, and University of California, San Francisco. For more information, visit www.nesos.com.